This week the World Health Organization (WHO) released its newly updated 4th WHO Model List of Essential Medicines for Children (EMLc), in which three treatments developed by the Drugs for Neglected Diseases initiative (DNDi) ...
Jul 11, 2013
0
0
Drugmaker Sanofi is abandoning two drugs in the late stages of development after trials revealed they weren't more effective than other therapies.
Jun 3, 2013
0
0
(AP)—French drug maker Sanofi said Thursday its net profit was slashed in the first quarter from a year earlier as falling sales and patent losses on key drugs combined to hammer earnings.
May 2, 2013
0
0
A Canadian high school student has improved an ineffective experimental cancer therapy with a simple tweak—pairing it with antibiotics—earning accolades Tuesday from a panel of eminent scientists.
Apr 9, 2013
0
0
French drugmaker Sanofi said Friday that it had begun building a new manufacturing facility in Vietnam to serve the expanding pharmaceutical market in southeast Asia.
Mar 29, 2013
0
0
French health care giant Sanofi Pasteur will soon test a vaccine against dengue fever in India amid concerns about the increasingly global spread of the disease, reports said Monday.
Nov 19, 2012
0
0
(HealthDay)—A single 10-minute, at-home treatment with topical ivermectin lotion eliminates head lice infestations in nearly all patients by the next day, according to a study published in the Nov. 1 issue of the New England ...
Nov 2, 2012
0
0
(HealthDay)—Addition of the fully human serum proprotein convertase subtilisin/kexin 9 monoclonal antibody, SAR236553, to atorvastatin is associated with greater reductions in low-density lipoprotein (LDL) cholesterol levels ...
Nov 2, 2012
0
0
(AP)—Bristol-Myers Squibb Co. and France's Sanofi SA said Wednesday that they are restructuring their longtime partnership selling popular heart medications, now that their sales are plunging due to widespread competition ...
Oct 3, 2012
0
0
(AP) — Drugmaker Sanofi saw its net profit rise 35 percent in the first half of the year as it pushes into areas with long-term growth potential to off-set the expiration of profitable patents.
Jul 26, 2012
0
0
